The AMPK/SIRT1 signaling pathway is an important pathway involved in regulating hepatic lipogenesis, which is regarded as a therapeutic target for the treatment of NAFLD 47, 48. Here, SIRT1 is linked to metabolic dysfunction-associated steatotic liver disease.